← Open Payments lookup

JILLIAN ADAMS: Open Payments

NPI 1033513031 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,467 in 65 payments from 12 companies in 2025. Trend: 2023 $2,851 · 2024 $3,101 · 2025 $2,467

Food & beverage: $2,467
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$444
Axsome Therapeutics, Inc.12$368
Alkermes, Inc.10$326
Otsuka America Pharmaceutical, Inc.6$259
E.R. Squibb & Sons, L.L.C.3$226
Collegium Pharmaceutical, Inc.2$214
ABBVIE INC.12$185
Lundbeck LLC7$174
Vanda Pharmaceuticals Inc.1$117
Tris Pharma Inc1$115

Products named: CAPLYTA, REXULTI, Auvelity, LYBALVI, COBENFY, Jornay PM, VRAYLAR, FANAPT.

Industry payments across TX — which companies pay providers there.